StockData
PCYNOTCPharmaceutical PreparationsFiscal year ends June 30

PROCYON CORP

Financials through Q4 FY2024, quarter ended Jun 30, 2024Last filing: 10-K on Oct 25, 2024
$0.18−0.09 (-31.48%)

Close on Oct 19, 2026

Market cap
$1.51M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Procyon has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Procyon filed with the SEC

  • FORM 8-K

    Event dated Nov 8, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated Oct 22, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated Aug 1, 2023, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 13, 2023, from SEC EDGAR

  • FORM 8-K

    Event dated Nov 9, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 28, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 16, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 6, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated May 12, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 13, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 29, 2020, from SEC EDGAR

  • FORM 8-K

    Event dated May 15, 2020, from SEC EDGAR